Diffusion Pharmaceuticals LLC, a clinical stage
drug development company, received approval from the
Food and Drug Administration to start human trials of
trans sodium crocetinate, which may hold promise in the
treatment of stroke, myocardial infarction and respiratory
disease. (Virginia Biotechnology Assoc.)
NTELOS Wireless, a Waynesboro-based telecommunications
company, will offer customers a trial program for an
unlimited nationwide rate plan. Complete nationwide coverage
with no roaming or overage charges will be available
for $99.99, allowing calls anywhere within the U.S. to
anywhere else in the country. (News release)
The University of Virginia’s
School of Engineering and Applied Science will partner with Central
Virginia Community College and AREVA NP of Lynchburg
on a pilot program that will allow students to earn
a four-year engineering degree without leaving the
Lynchburg area, through a combination of distance learning
and on-site classes. (News release)
